Volume 7, Issue 2 (2022)                   SJMR 2022, 7(2): 95-101 | Back to browse issues page

XML Persian Abstract Print


1- Department of Internal Medicine, Shahid Rajaei Educational and Therapeutic Medical Center, Karaj, Iran
2- Student Research Committee, Arak University of Medical Sciences, Arak, Iran.
3- Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran. , p.mardi.med@gmail.com
Abstract:   (1010 Views)
Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma (NHL) worldwide, accounting for approximately 22% of newly diagnosed cases of B-cell NHL. Determining the prognosis of patients and choosing the appropriate treatment regimen has been discussed in many studies. In this article, we examine a case of a patient with diffuse large B cell lymphoma with very rare extensive metastases in PET-CT scan, who did not respond to the first line of treatment proposed in the valid guidelines, but the patient responded to the second line of treatment (R regimen -ICE) has been very significant.
Conclusion: This case shows that probably in cases where there is extensive involvement in the patient's PET-CT scan and the patient's prognosis is considered poor, IPI, R-ICE regimen can be used first line.
Article number: 4
Full-Text [PDF 722 kb]   (262 Downloads)    
Article Type: Case Report | Subject: Health and safety
Received: 2022/09/1 | Accepted: 2022/09/12 | Published: 2023/03/18

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.